InMed Pharmaceuticals

(OTC: IMLFF)
Healthcare  |  Drug Manufacturers - Specialty & Generic
0.25 0.0 0.0%
Stock Price | July 19, 2019, 3:43 p.m.
0 Followers
Bid: 0.243
Ask: 0.25
Prev. Close: 0.2463
52 Week Low: 0.217
52 Week High: 0.82
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, ocular, CNS, respiratory, metabolic diseases, and others.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Special Supplement 12/24/17

26 Comments
1 year ago

Premium Mid-Week Chat - 12/13/17

1 year ago

Premium Cannabis Stocks Review - Special Supplement 12/10/17

47 Comments
1 year ago

Premium Mid-Week Chat 11/15/17

28 Comments
1 year ago

Premium Mid-Week Chat - 02/08/17

10 Comments
2 years ago

Premium Cannabis Stock Review - AM Edition 09/03/15

2 Comments
3 years ago

Premium Mid-Week Chat - 03/05/15

4 Comments
4 years ago

Free WeedStock: Breakfast Presentations

4 years ago